Angioplasty Summit-TCT Asia Pacific :::CVRF:::

Meeting Information

Course Directors

Faculty
- International Faculty
- Korean Faculty

Live Case
Transmission Sites

Scientific Program
• Meeting at a Glance
• Program
- Main Arena
- Coronary Arena
- Endovascular Arena
- Syposium Arena
- Room 4-1
- Breakfast Meetings
- Satellite Symposia
- Oral Abstract
      Competition
- Complex Case
      Competition
- Live Case Operators
- AMC Cardiac
      Rehabilitation
      Workshop
- Conference for
      Cardiovascular Nurse
      & Technologist

Daily Newspaper

Summit Live
Interview

Learning & Training!!

Best & Accepted
Challenging Case

Abstracts
- View E-poster Abstract

APSIC Convocation

Advance Registration

Housing

Exhibition
- General Info
- Exhibit Information
- Exhibitor List &
Floor Plan

Travel Information
- Most Attractive Spots
- Tour reservation
- Essential Information
- Visa
- Embassies

The most prominent faculty of the Angioplasty Summit-TCT Asia Pacific 2008 will share their experience and opinion in the interventional vascular field.

	Bernhard Chevalier, MD Centre Cardiologie du Nord, France - Thromboaspiration in AMI, Saphenous Vein Graft Intervention and NOBORI I Phase 2
	Antonio Colombo, MD Columbus Hospital and San Raffaele Hospital, Italy - True Bifurcation Lesion Intervention, Side Branch Interventions and CACTUS Trial
	Ted Feldman, MD Evanston Hospital, USA - Percutaneous Intervention in Valvular Heart Disease and Percutaneous Mitral Valve Repair
	Eulogio Garcia, MD Hospital Universitario Gregorio Marañón, Spain - Szabo Stenting Technique and Differences in Coronary Intervention Between Asia and Europe
	Eberhard Grube, MD Heart Center Siegburg, Germany - Next Generation DES, SPIRIT II -2 Year F/U, STEALTH II Pivotal Trial, and XTENT System
	Ziyad M. Hijazi, MD Rush University Medical Center, USA - PFO Closure, ASD Closure and Coarctation of Aorta Stenting
	David R. Holmes, MD Mayo Clinic, USA - PCI is a Better Treatment Option Compared with CABG and COURAGE Trial
	Adnan Kastrati, MD Deutsches Herzzentrum München, Germany - ISAR-REACT 3 and ISAR-Left Main
	Spencer B. King III, MD Fuqua Heart Center, USA - What Do You Expect 30 Years from Now in the Field of Coronary Intervention?
	John R. Laird, Jr., MD UC Davis Medical Center, USA - The True-Lumen Reentry Device for Subintimal Angioplasty, SFA CTO Intervention, Carotid Stenting and AAA Intervention
	Thierry Lefèvre, MD Institut Hospitalier Jacques Cartier, France - Nordic Stent Technique Study, bifurcation Lesion Intervention and Euro CTO Club
	Martin B. Leon, MD NewYork-Presbyterian Hospital / Columbia University Medical Center, USA - The Hottest Issue in 2008 SCAI/ACCi2 Meeting, The Journey of PCI from Empiricism to EBM, The Long-Term Outcomes of the Second Generation DESs and Dedicated Bifurcation Stents
	Roxana Mehran, MD NewYork-Presbyterian Hospital / Columbia University Medical Center, USA - Clinical Trial Design, HORIZONS AMI Trial and Contrast Induced Nephropathy
	Bernhard Meier, MD Swiss Cardiovascular Center Bern, Switzerland - Percutaneous PFO Closure
	Gary S. Mintz, MD Cardiovascular Research Foundation, USA - IVUS Guided PCI in the Era of DES and Gray Scale IVUS, VH- and IB-IVUS
	Jeffrey J. Popma, MD St. Elizabeth Medical Center, USA - The Clinical Outcomes of DESs After 5 or 10 Years, Adjunctive Phamacology After DES Implantation and Next Generation Stents
	Nicolaus J. Reifart, MD Main Taunus Heart Institute, Germany - CTO intervention and Peripheral Intervention Device
	Patrick W. Serruys, MD Erasmus Medical Center, Thoraxcenter, The Netherlands - SPIRIT II Trial, SYNTAX Trial and DELFT Registry
	Takahiko Suzuki, MD Toyohashi Heart Center, Japan - CTO Intervention: Retrograde Approach and MDCT Effect
	David Paul Taggart, MD University of Oxford, United Kingdom - PCI vs. CABG for Left Main Lesions
	Renu Virmani, MD CV Path, Institute Inc., USA - The Best Imaging Modality to Identify Vulnerable Plaque and Next Generation DESs